National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 17202 [E9-8481]
Download as PDF
17202
Federal Register / Vol. 74, No. 70 / Tuesday, April 14, 2009 / Notices
Dated: April 7, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–8479 Filed 4–13–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 7, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–8481 Filed 4–13–09; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Aneurysm Trial.
Date: April 23, 2009.
Time: 3:15 p.m. to 5:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Richard D. Crosland, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS/Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
MSC 9529, Bethesda, MD 20892–9529, 301–
594–0635, rc218u@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Review of NINDS PPG on
CA∧2+ Signaling in Spines.
Date: April 24, 2009.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Ernest W Lyons, PhD,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–496–4056, lyonse@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
VerDate Nov<24>2008
17:36 Apr 13, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of a Public Consultation
Meeting on Proposed Revisions to the
NIH Guidelines for Research Involving
Recombinant DNA Molecule (NIH
Guidelines)
There will be a public consultation
meeting to solicit stakeholder input
regarding the proposed revisions to the
NIH Guidelines. The meeting will be
held on Tuesday, June 23, 2009 at the
Hyatt Regency Crystal City, 2799
Jefferson Davis Highway, Arlington,
Virginia, 22202, from approximately 8
a.m. to 5 p.m.
Discussions will focus on the
proposed revisions to the NIH
Guidelines which include: (1)
Broadening the scope of the NIH
Guidelines, which currently cover
laboratory and clinical research
involving DNA molecules created via
recombinant techniques (i.e., joining of
DNA molecules), to apply to nucleic
acids that are synthesized chemically or
by other means without the use of
recombinant technology; (2) Revising
the criteria for determining when the
introduction of a drug resistance trait
into a microorganism must be reviewed
by the Recombinant DNA Advisory
Committee and approved by the NIH
Director; and (3) Changing the level of
review required for recombinant or
synthetic experiments involving more
than one-half but less than two-thirds of
the genome of certain viruses in tissue
culture as described in Section III–E–1
of the NIH Guidelines.
The Notice of Consideration of a
Proposed Action under the NIH
Guidelines was published in the
Federal Register on March 4, 2009 (74
FR 9411) and may be located at the
following link: https://oba.od.nih.gov/
rdna/rdna.html.
For further information concerning
this meeting contact Ms. Laurie
Lewallen, Advisory Committee
Coordinator, Office of Biotechnology
Activities, Office of the Director,
National Institutes of Health, 6705
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Rockledge Drive, Room 750, Bethesda,
MD 20892–7985, 301–496–9838,
lewallenl@od.nih.gov.
The meeting will be open to the
public, with attendance limited to the
space available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed above in
advance of the meeting.
A draft agenda and additional
information for the meeting will be
posted on the OBA Web site: https://
oba.od.nih.gov/rdna/rdna.html.
Background and supplemental
information may also be obtained by
contacting NIH OBA by e-mail
oba@od.nih.gov.
Dated: April 8, 2009.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology
Activities, National Institutes of Health.
[FR Doc. E9–8478 Filed 4–13–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Research Sites To
Measure Composition of Sealed Area
Atmosphere in Coal Mines
AGENCY: National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice.
SUMMARY: The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC), is
seeking research sites to measure
composition of sealed area atmosphere
in coal mines.
NIOSH seeks to conduct scientific
studies of the composition of sealed area
atmospheres and the mechanisms of
methane accumulation within sealed
areas. Research questions to be
addressed are: (1) Whether potentially
explosive gas mixtures exist within
sealed areas, (2) how extensive such
mixtures might be, (3) how the gas
composition changes over time, (4)
whether methane layering exists, (5) the
homogeneity of the atmosphere, and (6)
how barometric pressure changes
impact the sealed atmosphere. NIOSH
will document measurements of the
composition of the sealed area
atmosphere over time, analyze the
E:\FR\FM\14APN1.SGM
14APN1
Agencies
[Federal Register Volume 74, Number 70 (Tuesday, April 14, 2009)]
[Notices]
[Page 17202]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-8481]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Aneurysm Trial.
Date: April 23, 2009.
Time: 3:15 p.m. to 5:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Richard D. Crosland, PhD, Scientific Review
Administrator, Scientific Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892-9529, 301-594-0635,
rc218u@nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Review of NINDS PPG on
CA[supcaret]2+ Signaling in Spines.
Date: April 24, 2009.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Ernest W Lyons, PhD, Scientific Review
Administrator, Scientific Review Branch, NINDS/NIH/DHHS Neuroscience
Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD
20892-9529, 301-496-4056, lyonse@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: April 7, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-8481 Filed 4-13-09; 8:45 am]
BILLING CODE 4140-01-P